Bausch + Lomb
bausch.lv
Actively hiring
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
BAUSCH + LOMB. ''Bausch + Lomb'' ir viena no pasaules līderu kompānijām, kuras ražo produktus acu veselībai.Kompānijas produktu klāsts apņem visu produktu spektru, saistītu ar acu veselības kopšanu - no redzes korekcijas produktiem līdz medikamentiem un ķirurģiskām iekārtam.
News
Report
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
While Bausch + Lomb's dual-action eye drops failed to outperform active comparators at day 29, the investigational asset showed significant superiority at day 15.
Read more
Report
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
Strong operating results did not stop one fund from walking away entirely, raising questions about how much patience volatile healthcare names really command.
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.